Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques

T Nilsson, J Longmore, D Shaw, E Pantev… - European journal of …, 1999 - Elsevier
5-Hydroxytryptamine (5-HT) can produce both vasoconstrictor and vasorelaxant effects in
human coronary arteries and the response to 5-HT can be influenced by the presence of …

Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure

M Hou, M Malmsjö, S Möller, E Pantev, A Bergdahl… - Life sciences, 1999 - Elsevier
We wanted to study the expression of P2-receptors at the mRNA-level in the heart and if it is
affected by congestive heart failure (CHF). To quantify the P2 receptor mRNA-expression we …

Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5′-O-thiodiphosphate and uridine 5′-O-3 …

…, M Hou, TK Harden, W Pendergast, E Pantev… - … of Pharmacology and …, 2000 - ASPET
The present study was designed to evaluate the relative contribution of the different contractile
P2 receptors in endothelium-denuded human coronary arteries by use of extracellular …

Effects of administration of iron isomaltoside 1000 in patients with chronic heart failure. A pilot study

…, NE BRUUN, OW NIELSEN, E PANTEV… - Transfusion …, 2010 - Wiley Online Library
Intravenous iron preparations have shown benefit in patients with chronic heart failure (CHF)
and iron deficiency. Iron isomaltoside 1000 (Monofer) is a novel intravenous iron …

[HTML][HTML] Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy

…, F Morandi, H Mølgaard, F Oliva, E Pantev… - International journal of …, 2017 - Elsevier
Patients in the latest stages of heart failure are severely compromised, with poor quality of
life and frequent hospitalizations. Heart transplantation and left ventricular assist device …

Safety and efficacy of valsartan versus enalapril in heart failure patients

R Willenheimer, C Helmers, E Pantev… - International journal of …, 2002 - Elsevier
Although a cornerstone in the treatment of heart failure, angiotensin-converting enzyme
inhibitors are under-used, partly due to side effects. If proven at least similarly efficacious to …

Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries

E Pantev, E Stenman, A Wackenfors… - European Journal of …, 2002 - Wiley Online Library
Background: Angiotensin II (Ang II) is a potent vasoconstrictor and a deleterious factor in
cardiovascular pathophysiology. Ang II receptor blockers (ARBs) have recently been introduced …

Angiotensin II receptor mRNA expression and vasoconstriction in human coronary arteries: effects of heart failure and age

A Wackenfors, E Pantev, M Emilson… - Basic & clinical …, 2004 - Wiley Online Library
Angiotensin II is a potent vasoconstrictor that is implicated in the pathogenesis of hypertension,
heart failure and atherosclerosis. In the present study, angiotensin II receptor mRNA …

Pharmacokinetic evaluation of a case of massive sotalol intoxication

…, E Vinge, BO Norlander, E Pantev - Annals of …, 1997 - journals.sagepub.com
OBJECTIVE: To describe serum concentrations and clearance of sotalol after a massive
overdose. CASE SUMMARY: A 37-year-old white man took 11.2 g of sotalol hydrochloride …

Inhibition of angiotensin II-induced contraction by losartan in human coronary arteries

A Holmgren, E Pantev, D Erlinge… - Journal of …, 1998 - journals.lww.com
The in vitro effects of angiotensin II (Ang II) in human vessels are not well studied. The
development of specific Ang II-receptor antagonists has made it possible to delineate more …